Gene · 6614
Papers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,964
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IFN-related gene expression defines disease activity, organ involvement and treatment response in JDM. | Rheumatology (Oxford) | 2026 | 42500994 | PubTator, text mining | PubMed |
| Integrated spatially guided transcriptomics and multiplex imaging identify a high-risk CD163+/CD11c-subgroup in diffuse large B-cell lymphoma. | Haematologica | 2026 | 42489074 | PubTator, text mining | PubMed |
| Siglec-1 upregulation and macrophage activation in age-related hearing loss: insights from integrated transcriptomic studies in mice and humans. | Front Cell Neurosci | 2026 | 42464994 | PubTator, text mining | PubMed |
| A human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defense. | Proc Natl Acad Sci U S A | 2026 | 42461768 | PubTator, text mining | PubMed |
| Tumor-distant pulmonary immune landscapes are associated with postoperative outcomes in non-small cell lung cancer. | Transl Lung Cancer Res | 2026 | 42433237 | PubTator, text mining | PubMed |
| CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies. | Front Immunol | 2026 | 42421954 | PubTator, text mining | PubMed |
| Serum sialic acid binding immunoglobulin-like lectin-1 (sSIGLEC-1) in Egyptian patients with lupus nephritis: correlation with renal activity in non-European ancestry. | Sci Rep | 2026 | 42410020 | PubTator, text mining | PubMed |
| Predictive Value of First-Trimester Serum TREM2 and SIGLEC1 Levels for Adverse Pregnancy Outcomes in Women with PCOS. | Int J Gen Med | 2026 | 42369564 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| Stage-associated remodeling of CD169 macrophage states is linked to immune regulation in colitis-associated colorectal cancer. | J Gastroenterol | 2026 | 42342977 | PubTator, text mining | PubMed |
| Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cells. | Front Immunol | 2026 | 42327736 | PubTator, text mining | PubMed |
| A macrophage-targeted bivalent saRNA vaccine protects against ocular and cutaneous HSV-1 infection in mice. | J Control Release | 2026 | 42264387 | PubTator, text mining | PubMed |
| The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes. | Endocr J | 2026 | 42236230 | PubTator, text mining | PubMed |
| The spleen-heart crosstalk in cardiovascular disease: integrating neural, immune, and secretory pathways. | Acta Pharmacol Sin | 2026 | 42185683 | PubTator, text mining | PubMed |
| CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skin. | J Exp Med | 2026 | 42166711 | PubTator, text mining | PubMed |
| Dyslipidemia is associated with monocyte lipid metabolic reprogramming in Guillain-Barré syndrome. | Front Neurol | 2026 | 42051772 | PubTator, text mining | PubMed |
| Respiratory syncytial virus-induced SIGLEC1 upregulation inhibits macrophage autophagy and facilitates inflammatory mediator secretion. | BMJ Open Respir Res | 2026 | 42009498 | PubTator, text mining | PubMed |
| Establishiment of PANoptosis-related prognostic signature and experimental identification of SIGLEC1 as an oncogenic biomarker in endometrial cancer. | Discov Oncol | 2026 | 41998299 | PubTator, text mining | PubMed |
| High baseline CD317 expression on T cells predicts favorable anifrolumab response in systemic lupus erythematosus. | Front Immunol | 2026 | 41972144 | PubTator, text mining | PubMed |
| Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. | Science | 2026 | 41955354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6614/papers?page=2